Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 216-971-0 | CAS number: 1709-70-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- three-generation reproductive toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Not Specified
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study report does not specify a guideline followed, however results are quite deatiled for F2 & F3 generations.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 970
- Report date:
- 1970
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Not specified
- Principles of method if other than guideline:
- Ionox 330 was fed to rats at dietary concentrations of 0 and 5,000 ppm. Observations were made on the health, body weight and food intake of each animal At 14 weeks of age one male and one female from a treatment group were selected at random and caged together for mating. Three litters were bred from each pair for three successive generations. The final litter from the third generation was examined for any evidence of teratogenic effects.
- GLP compliance:
- no
- Limit test:
- yes
Test material
- Reference substance name:
- 3,3',3'',5,5',5''-hexa-tert-butyl-α,α',α''-(mesitylene-2,4,6-triyl)tri-p-cresol
- EC Number:
- 216-971-0
- EC Name:
- 3,3',3'',5,5',5''-hexa-tert-butyl-α,α',α''-(mesitylene-2,4,6-triyl)tri-p-cresol
- Cas Number:
- 1709-70-2
- Molecular formula:
- C54H78O3
- IUPAC Name:
- 3,3',3'',5,5',5''-hexa-tert-butyl-α,α',α''-(mesitylene-2,4,6-triyl)tri-p-cresol
- Details on test material:
- A 100 kg sample of Ionox 330, batch No, 89/5/6232, purity 98%, was supplied by Shell Chemicals U.K.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Carworth Farm E
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- 80 rats of the Carworth Farm E strain were used. These animals were bred and maintained under specific-pathogen-free conditions at this laboratory.
Groups of 20 male and 20 female rats, aged three weeks (FO), received diets (Diet 86, Scientific Products Farm).
The animals were caged in groups of two of each sex and given the appropriate diet. At 14 weeks of age, one male and one female from within a treatment group were selected at random and caged together for mating.
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- Not specified
- Details on mating procedure:
- At 14 weeks of age, one male and one female from within a treatment group were selected at random and caged together for mating. The pair remained together throughout the experiment and three litters were bred (F1a, F1b and F1c).
Litters F1a and F1c were killed at weaning. From each treatment group, one male and one female from each of the weaned second litters (F1b) were selected at random and fed the appropriate treatment diet. The rats were kept as for the FO generation, paired and mated when 100 days old. Three litters were bred (F2a, F2b and F2c), a selection made as before from F2b to produce the third generation litters, F3a, F3b and F3c. - Analytical verification of doses or concentrations:
- not specified
- Details on analytical verification of doses or concentrations:
- No data
- Duration of treatment / exposure:
- Not specified
- Frequency of treatment:
- Daily
- Details on study schedule:
- At 14 weeks of age, one male and one female from within a treatment group were selected at random and caged together for mating. The pair remained together throughout the experiment and three litters were bred (F1a, F1b and F1c). Litters F1a and F1c were killed at weaning. From each treatment group, one male and one female from each of the weaned second litters (F1b) were selected at random and fed the appropriate treatment diet. The rats were kept as for the FO generation, paired and mated when 100 days old. Three litters were bred (F2a, F2b and F2c), a selection made as before from F2b to produce the third generation litters, F3a, F3b and F3c.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 5000 ppm
Basis:
nominal in diet
- No. of animals per sex per dose:
- FO generation: 20 males & 20 females per dose group
- Control animals:
- yes, plain diet
- Details on study design:
- Not specified
- Positive control:
- Not specified
Examinations
- Parental animals: Observations and examinations:
- Daily observations were made on general health and behaviour of all animals. Records were kept of dates of mating, intervals between mating and number of pregnancies. The number of young in each litter were counted at birth, after five days and at weaning (21 days). Litters were culled to 12 at birth.
- Oestrous cyclicity (parental animals):
- Not specified
- Sperm parameters (parental animals):
- Not specified
- Litter observations:
- Daily observations were made on general health and behaviour of all animals. Records were kept of dates of mating, intervals between mating and number of pregnancies. The number of young in each litter were counted at birth, after five days and at weaning (21 days). Litters were culled to 12 at birth.
- Postmortem examinations (parental animals):
- Not specified
- Postmortem examinations (offspring):
- Not specified
- Statistics:
- Statistical analyses of body and organ weights were made using the initial body weight as a covariate in covariance analysis.
The data from the litters were examined using analysis of variance.
The significance of any difference between the treatment and control groups of animals was measured using the Student 't' test. - Reproductive indices:
- Data produced in the results
- Offspring viability indices:
- Data produced in the results
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- not specified
- Histopathological findings: non-neoplastic:
- not specified
- Other effects:
- not specified
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- not specified
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- no effects observed
Details on results (P0)
Effect levels (P0)
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- > 5 000 ppm (nominal)
- Sex:
- male/female
- Dose descriptor:
- NOAEL
- Effect level:
- > 5 000 ppm (nominal)
- Sex:
- male/female
- Remarks on result:
- other: Generation: F3 (migrated information)
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Sexual maturation:
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- no effects observed
Details on results (F1)
Dietary concn (ppm): 0
Pair No 80a: Male and female – peribronchial cuffing; medial hypertrophy of branches of pulmonary artery; foci of alveolar macrophages in lung; few basophilic tubles in kidney; serous cysts in ovary.
Pair No 81: Male – Focal myocardial fibrosis; moderately severe chronic nephrosis. Female – Focal centrilobular fatty change in liver; few basophilic tubles in kidneys.
Pair No 82: Male and female – broken colloid in thyroid; focal myocardial fibrosis; mild to focal peribronchial cuffing and mild to moderately severe chronic nephrosis. Medial hypertrophy of branches of pulmonary artery; focal ductule hyperplasia in liver; a focus of fatty change in liver parenchyma (male only); mild peribronchial cuffing; generalised fatty change in liver with increased mitotic activity (female only).
Pair No 83: Male – Peribronchial cuffing; mild chronic nephrosis. Female – Peribronchial cuffing and aggregates of alveolar macrophages in lung.
Pair No 84: Male and female – some broken colloid in thyroid; peribronchial cuffing and aggregates of alveolar macrophages in lung; mild to chronic nephrosis. Centrilobular fatty change in liver with foci of ductile hyperplasia; focal myocardial fibrosis (male only).
Pair No 85: Male – some broken colloid in thyroid; focal myocardial fibrosis; moderately severe chronic nephrosis. Female – few basophilic tubes in kidneys.
Pair No 86: Male and female – focal myocardial fibrosis; mild and focus of peribronchial cuffing and medial hypertrophy in branches of pulmonary artery; mild chronic and focal nephrosis. Medial hypertrophy of branches of splenic artery (female only).
Pair No 87: Male – focal myocardial fibrosis; focal peribronchial cuffing; mild chronic nephrosis. Female – poorly stained thyroid colloid; peribronchial cuffing; medial hypertrophy of a branch of pulmonary artery; foci of alveolar macrophages; focal fatty change in the liver; mild chronic nephrosis; deciduoma in uterus.
Pair No 88: Male – poorly stained thyroid colloid; medial hypertrophy of branches of coronary artery; focal peribronchial cuffing; a focus of ductile hyperplasia in liver; mild chronic nephrosis; unilateral atrophy of semiferous epithelium of testes. Female – Focal myocardial fibrosis; peribronchial cuffing; raised mitotic rate in liver; mild chronic nephrosis.
Pair No 89: Male and female –peribronchial cuffing and medial hypertrophy of branch of pulmonary artery; mild chronic nephrosis. Poorly stained thyroid colloid (male only); few aggregates of alveolar macrophages in lung (female only).
Pair No 91: Male – poorly stained thyroid colloid; focal myocardial fibrosis; centrilobular fatty change in liver. Female – peribronchial cuffing and aggregates of alveolar macrophages in lung; mild chronic nephrosis.
Pair No 92: Male and female – focal myocardial fibrosis; mild peribronchial cuffing and medial hypertrophy of branches of pulmonary artery. Poorly stained thyroid colloid; minute foci of myocarditis in papillary muscle of heart; mild ductile proliferation in liver; mild chronic nephrosis (male only); dilated kidney tubles, a few lined by basophilic epithelium (female only).
Pair No 93: Male and female –mild peribronchial cuffing; medial hypertrophy of a branch of pulmonary artery. Poorly stained thyroid colloid; aggregates of alveolar macrophages with lymphocytes; isolated nephritic tubles in kidneys (male only); foci of alveolar macrophages; mild chronic nephrosis; medial hypertrophy of a branch of renal artery (female only).
Pair No 94: Male and female –mild to focal peribronchial cuffing; focal lipid vacuolation in liver. Poorly stained thyroid colloid; foci of myocardial fibrosis; severe chronic nephrosis (male only); foci of alveolar macrophages in lung; few basophilic tubles in kidney; uterine carcinoma (female only).
Pair No 95: Male and female –mild peribronchial cuffing; foci and few aggregates of alveolar macrophages in lung; mild chronic nephrosis. Poorly stained thyroid colloid; focus of ductile hyperplasia in liver (male only); medial hypertrophy of branches of pulmonary artery (female only).
Pair No 96: Male and female –medial hypertrophy of a branch of pulmonary artery. Mild peribronchial cuffing; foci of alveolar macrophages; mild chronic nephrosis with protein droplet formation in tubular epithelium (male only); few basophilic tubles in kidneys (female only).
Pair No 97: Male and female – mild peribronchial cuffing in lungs; few basophilic tubles in kidneys. Minute foci of myocarditis; foci of alveolar macrophages; medial hypertrophy of a branch of pulmonary artery (female only).
Pair No 98: Male – poorly stained thyroid colloid; mild peribronchial cuffing in lung; mild chronic nephrosis. Female – focal myocardial fibrosis; focal fatty change and patchy congestion in liver; mild chronic nephrosis.
Pair No 99: Male – poorly stained thyroid colloid; mild peribronchial cuffing; medial hypertrophy of branch of pulmonary artery; mild chronic nephrosis. Female – mild peribronchial cuffing; few basophilic tubles in kidney; deciduoma in uterus.
Dietary concn (ppm): 5000
Pair No 100: Male and female – poorly stained thyroid colloid; focal myocardial fibrosis; peribronchial cuffing; foci of alveolar macrophages in lung; mild chronic nephrosis. Medial hypertrophy of branches of pulmonary artery; focal centrilobular fatty change in liver (male only).
Pair No 101: Male and female –mild peribronchial cuffing; mild chronic nephrosis. Poorly stained thyroid colloid (male only); focal myocardial fibrosis; medial hypertrophy of branches of pulmonary artery; foci of alveolar macrophages in lungs (female only).
Pair No 102: Male – poorly stained thyroid colloid; focal myocardial fibrosis; mild peribronchial cuffing; mild chronic nephrosis. Female – focal peribronchial cuffing; medial hypertrophy of a branch of pulmonary artery; foci of alveolar macrophages in lung; mild chronic nephrosis; ovarian cyst, probably of follicular origin.
Pair No 103: Male and female – focal myocardial fibrosis; mild peribronchial cuffing; medial hypertrophy of a branch of pulmonary artery; foci of alveolar macrophages in lungs; mild chronic nephrosis. Minute congenital cyst in parathyroid (male only); small hyperplastic nodules in adrenal cortex (female only).
Pair No 104: Male – poorly stained thyroid colloid; peribronchial cuffing; centrilobular fatty change in liver; moderately severe chronic nephrosis; focal ductile proliferation in pancreas. Female – focal myocardial fibrosis; mild chronic nephrosis.
Pair No 105: Male and female –mild to focal peribronchial cuffing; medial hypertrophy of a branch of pulmonary artery; fatty change in liver. Poorly stained thyroid colloid; focal myocardial fibrosis; mild chronic nephrosis (male only); a few basophilic tubles in kidneys with calcification of renal papillae (female only).
Pair No 106: Male and female –focal peribronchial cuffing; medial hypertrophy of branches of pulmonary artery; mild to severe chronic nephrosis. Poorly stained thyroid colloid; focal myocardial fibrosis; foci of alveolar macrophages; an area of vaculoation and degeneration of acinar cells of exocrine pancreas; associated with mild ductile hyperplasia (male only).
Pair No 107: Male – poorly stained thyroid colloid; focal peribronchial cuffing; medial hypertrophy of some branches of pulmonary artery; a focus of ductile hyperplasia in liver. Female – focal peribronchial cuffing; a focus of alveolar macrophages in lung; periportal fatty change and increase in mitotic rate in liver; a focus of ductile hyperplasia in pancreas and vacuolation and degeneration of a few acinar cells.
Pair No 108: Male and female –focal myocardial fibrosis; peribronchial cuffing; medial hypertrophy of some branches of pulmonary artery; mild to severe chronic nephrosis. Poorly stained thyroid colloid; a focus of ductile proliferation in pancreas (male only); focal ductile hyperplasia in a few portal areas in liver (female only).
Pair No 109: Male and female –peribronchial cuffing; medial hypertrophy of some branches of pulmonary artery; mild chronic nephrosis. Poorly stained thyroid colloid; focal myocardial fibrosis (male only); congenital cyst in the thyroid; foci of alveolar macrophages in lung; a decidumoa in uterus (female only).
Pair No 110: Male and female –mild peribronchial cuffing; medial hypertrophy of some branches of pulmonary artery; focal fatty change in liver; mild to moderately severe chronic nephrosis. Poorly stained thyroid colloid; minute foci of ductile hyperplasia in pancreas (male only); focal myocardial fibrosis (female only).
Pair No 111: Male – poorly stained thyroid colloid; advanced fibrosis of papillary muscle in the heart; peribronchial cuffing; arteriosclerotic lesion of part wall of branch of pulmonary artery; foci of alveolar macrophages in lungs; excess haemosiderin in red pulp of the spleen; severe chronic nephrosis. Female – focal myocardial fibrosis; focal peribronchial cuffing; medial hypertrophy of a branch of pulmonary artery; a few basophilic tubles in kidneys.
Pair No 112: Male and female –focal myocardial fibrosis; peribronchial cuffing; medial hypertrophy of branches of pulmonary artery. Poorly stained thyroid colloid; chronic nephrosis (male only); a few basophilic tubles in kidneys (female only).
Pair No 113: Male and female –medial hypertrophy of branches of pulmonary artery; mild chronic nephrosis. Poorly stained thyroid colloid; focal myocardial fibrosis (male only); peribronchial cuffing; foci of alveolar macrophages in lung (female only).
Pair No 114: Male – poorly stained thyroid colloid; peribronchial cuffing; medial hypertrophy of branches of pulmonary artery; foci of alveolar macrophages in lung; moderately severe chronic nephrosis; focal vacuolation of exocrine secretory cells and mild ductile proliferation in pancreas. Female – peribronchial cuffing; minute focus of ductile hyperplasia in liver; moderately severe chronic nephrosis.
Pair No 115: Male – poorly stained thyroid colloid; ultimo-branchial cysts; focal myocardial fibrosis; peribronchial cuffing; mild chronic nephrosis.
Pair No 116: Male – poorly stained thyroid colloid; focal myocardial fibrosis; medial hypertrophy of branches of pulmonary artery; very severe chronic nephrosis. Female – medial hypertrophy of a branch of pulmonary artery; foci of alveolar macrophages in lung; pyelonephritis; a focus of ductile hyperplasia in pancreas; cystitis; focal arteriosclerosis of the aorta.
Pair No 117: Male and female – poorly stained thyroid colloid; focal myocardial fibrosis; mild peribronchial cuffing; medial hypertrophy of branches of pulmonary artery; foci of alveolar macrophages in lung. Mild chronic nephrosis (male only); few basophilic tubles in kidneys; arteriosclerot lesion in wall of major artery in thorax (female only).
Pair No 118: Male – poorly stained thyroid colloid; focal peribronchial cuffing; focus of ductile hyperplasia liver; mild chronic nephrosis. Female – mild peribronchial cuffing; medial hypertrophy of some branches of pulmonary artery; centrilobular fatty change in lover; mild chronic nephrosis; medial hypertrophy of branch of pancreatic artery.
Pair No 119: Male and female – peribronchial cuffing and focal hypertrophy of media branches of pulmonary artery; mild chronic nephrosis.
Effect levels (F1)
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- > 5 000 ppm (nominal)
- Sex:
- male/female
Results: F2 generation
Effect levels (F2)
- Dose descriptor:
- NOAEL
- Generation:
- F2
- Effect level:
- > 5 000 ppm (nominal)
- Sex:
- male/female
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Any other information on results incl. tables
Reproductive performance of rats fed Ionox 330
Dietary concn (ppm) |
No of pregnancies |
No of young born |
No of young born alive |
No of young alive after 21 days |
Fertility (a) Index |
Gestation (b) Index |
Viability (c) Index |
Lactation (d) Index |
||
|
GENERATION 1 |
|||||||||
|
Litter F1a |
|||||||||
0 |
19/20 |
220 |
(11.6)+ |
218 |
(11.5)+ |
181 |
95 |
100 |
99.1 |
83.0 |
5000 |
19/20 |
221 |
(11.6) |
218 |
(11.5) |
158 |
95 |
100 |
98.6 |
72.5 |
|
Litter F1b |
|||||||||
0 |
19/20 |
178 |
(9.4) |
178 |
(9.4) |
140 |
95 |
100 |
100 |
78.7 |
5000 |
19/20 |
171 |
(9.0) |
171 |
(9.0) |
130 |
95 |
100 |
100 |
76.0 |
|
Litter F1c |
|||||||||
0 |
19/20 |
187 |
(9.8) |
187 |
(9.8) |
160 |
95 |
100 |
100 |
85.6 |
5000 |
19/20 |
192 |
(10.1) |
192 |
(10.1) |
167 |
95 |
100 |
100 |
87.0 |
|
GENERATION 2 |
|||||||||
|
Litter F2a |
|||||||||
0 |
20/20 |
236 |
(11.8) |
236 |
(11.8) |
173 |
100 |
100 |
100 |
73.3 |
5000 |
20/20 |
223 |
(11.2) |
223 |
(11.2) |
207 |
100 |
100 |
100 |
92.8 |
|
Litter F2b |
|||||||||
0 |
20/20 |
190 |
(9.5) |
190 |
(9.5) |
175 |
100 |
100 |
100 |
92.1 |
5000 |
20/20 |
190 |
(9.5) |
190 |
(9.5) |
183 |
100 |
100 |
100 |
96.3 |
|
Litter F2c |
|||||||||
0 |
20/20 |
209 |
(10.5) |
209 |
(10.5) |
189 |
100 |
100 |
100 |
90.4 |
5000 |
*19/20 |
169 |
(8.9) |
169 |
(8.9) |
157 |
95 |
100 |
100 |
92.9 |
|
GENERATION 3 |
|||||||||
|
Litter F3a |
|||||||||
0 |
19/20 |
219 |
(11.5) |
219 |
(11.5) |
204 |
95 |
100 |
100 |
93.2 |
5000 |
20/20 |
232 |
(11.6) |
232 |
(11.6) |
217 |
100 |
100 |
100 |
93.5 |
|
Litter F3b |
|||||||||
0 |
18/20 |
189 |
(10.5) |
189 |
(10.5) |
181 |
90 |
100 |
100 |
95.8 |
5000 |
20/20 |
189 |
(9.5) |
189 |
(9.5) |
172 |
100 |
100 |
100 |
91.0 |
|
Litter F3c |
|||||||||
0 |
18/20 |
178 |
(9.9) |
178 |
(9.9) |
165 |
90 |
100 |
100 |
92.7 |
5000 |
20/20 |
207 |
(10.4) |
207 |
(10.4) |
191 |
100 |
100 |
100 |
92.3 |
* Female sent to pathology
+ Average number of pups/litter
(a) - % matings resulting in pregnancies
(b) - % pregnancies resulting in birth of live litters
(c) - % of young born alive after 2 days
(d) - % young alive after 2 days surviving to weaning at 21 days
Applicant's summary and conclusion
- Conclusions:
- In conclusion feeding Ionox 330 to rats at a dietary concentration of 5,000 ppm for three generations produced no effects upon reproduction. No gross or histological evidence was found of congenital abnormalities attributable to Ionox 330.
- Executive summary:
Ionox 330 was fed to rats at dietary concentrations of 0 and 5,000 ppm. Observations were made on the health, body weight and food intake of each animal At 14 weeks of age one male and one female from a treatment group were selected at random and caged together for mating. Three litters were bred from each pair for three successive generations. The final litter from the third generation was examined for any evidence of teratogenic effects.
Ionox 330 when fed to rats at a dietary concentration of 5,000 ppm for three generations produced no effects upon reproduction. No gross or histological evidence was found of any congenital abnormalities attributable to Ionox 330.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.